Thousands of cold and flu products could be on the chopping block after the FDA proposed to pull medications from store shelves that contain phenylephrine.
(Alliance News) - AstraZeneca PLC on Friday said it received positive results from a trial of Tezspire as a treatment for chronic rhinosinusitis with nasal polyps.